TMCnet News
The Market for Molecular Histology and Cytology (HPV, in situ hybridization, CTCs, Flow Cytometry) - Research and MarketsResearch and Markets (http://www.researchandmarkets.com/research/nt7vpn/the_market_for) has announced the addition of the "The Market for Molecular Histology and Cytology (HPV, in situ hybridization, CTCs, Flow Cytometry)" report to their offering. In Situ Hybridization, HPV Testing, Circulating Tumor Cells and Flow Cytometry are important histology and cytology approaches to testing. In situ hybridization and more specifically fluorescent in situ hybridization (FISH) techniques use DNA probes to detect pathogens and molecular structures in cells. More recently flow cytometry techniques and other cell capture devices allow lab professionals to select targeted cells that can be further analyzed with PCR (News - Alert), sequencing and mass spectrometry. The result so far has been gene patterns that help distinguish cell and tumor attributes that demonstrate the presence of diseae as well as risk for disease progression and sensitivity to specific therapeutics. A growing population of cancer patients has increased the number of histology analyses performed. This report contains market sizes and forecasts for these technologies, identifies drivers and market trends, and identifies the competitive situation in the market. Companies Mentioned:
Key Topics Covered: Chapter 1 - Executive Summary Chapter 2 - Market Analysis Chapter 3 - Company Profiles For more information visit http://www.researchandmarkets.com/research/nt7vpn/the_market_for View source version on businesswire.com: http://www.businesswire.com/news/home/20160118005419/en/ |
